Gene · 2203
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. | EMBO Rep | 2023 | 36794620 | PubTator, text mining | PubMed |
| Emerging landscape of circFNDC3B and its role in human malignancies. | Front Oncol | 2023 | 36793611 | PubTator, text mining | PubMed |
| By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma. | Front Immunol | 2023 | 36776843 | PubTator, text mining | PubMed |
| Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase. | Nutrients | 2023 | 36771285 | PubTator, text mining | PubMed |
| The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36769116 | PubTator, text mining | PubMed |
| Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates. | ACS Infect Dis | 2023 | 36762976 | PubTator, text mining | PubMed |
| The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials. | Front Oncol | 2023 | 36756159 | PubTator, text mining | PubMed |
| Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review). | Int J Oncol | 2023 | 36734270 | PubTator, text mining | PubMed |
| Immune-based prognostic biomarkers associated with metastasis of osteosarcoma. | Gen Physiol Biophys | 2023 | 36705300 | PubTator, text mining | PubMed |
| One-shot 13 C15 N-metabolic flux analysis for simultaneous quantification of carbon and nitrogen flux. | Mol Syst Biol | 2023 | 36705093 | PubTator, text mining | PubMed |
| Expression of fructose-1,6-bisphosphatase 1 is associated with [18F]FDG uptake and prognosis in patients with mesial temporal lobe epilepsy. | Eur Radiol | 2023 | 36692596 | PubTator, text mining | PubMed |
| The Beneficial Effects of Pine Nuts and Its Major Fatty Acid, Pinolenic Acid, on Inflammation and Metabolic Perturbations in Inflammatory Disorders. | Int J Mol Sci | 2023 | 36674687 | PubTator, text mining | PubMed |
| Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 36672433 | PubTator, text mining | PubMed |
| Schlafen 12 Slows TNBC Tumor Growth, Induces Luminal Markers, and Predicts Favorable Survival. | Cancers (Basel) | 2023 | 36672349 | PubTator, text mining | PubMed |
| The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. | Cancers (Basel) | 2023 | 36672305 | PubTator, text mining | PubMed |
| Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression. | Cells | 2023 | 36672169 | PubTator, text mining | PubMed |
| Metformin acts in the gut and induces gut-liver crosstalk. | Proc Natl Acad Sci U S A | 2023 | 36656866 | PubTator, text mining | PubMed |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | 36648960 | PubTator, text mining | PubMed |
| Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis. | Cell Res | 2023 | 36646759 | PubTator, text mining | PubMed |
| 1,25-Dihydroxyvitamin D regulates macrophage activation through FBP1/PKR and ameliorates arthritis in TNF-transgenic mice. | J Steroid Biochem Mol Biol | 2023 | 36646150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2203/papers?page=19